1.
J Pediatr
; 270: 114040, 2024 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38554746
RESUMO
Infants with severe bronchopulmonary dysplasia may require high doses of neurosedative medications to ensure pain control and stability following tracheostomy placement. Subsequent weaning of these medications safely and rapidly is a challenge. We describe a 24-hour propofol infusion to reduce neurosedative medications in 3 high-risk infants following tracheostomy placement.